Skip to main content

CAR T studies with significantly delayed onset of GvHD

Assessing efficacy and toxicity in CAR-T studies in an accessible translational model. The Jackson Laboratory's in vivo PBMC-humanized mouse platform provides a wider window to look at cytokine release with significantly delayed onset of GvHD.